去氨基 deamination ; deaminization
使脱去氨基 deaminate
去氨加压素 Minirin ; DDAVP ; Desmopressin
去氨木香内酯 Dehydrocostus lactone
腺嘌呤去氨酵素缺损 Adenosine Deaminase Deficiency, ADA ; Adenosine Deaminase Deficiency
醋酸去氨加压素注射液 Minirin ; Desmopressin Acetate Injection
去氨基甲酰化常数 decarbamylation constant
醋酸去氨加压素 Desmopressin ; Desmopressin acetate
去甲氨噻肟酸乙酯 EHATA
目的了解和分析去氨加压素在临床应用中不良反应，促进临床合理用药。
Objective To study the adverse drug reaction (ADR) of desmopressin (DDAVP) in clinical application, improving clinical medication.
如果患者需要要继续用药，应选择口服去氨加压素，并且从最低剂量开始增量，直到控制住症状。
If ongoing treatment is considered necessary, patients should be switched to the lowest starting dose of an oral formulation, with the dose increased only if necessary to control symptoms.
在经皮肾穿刺患者中，穿刺前给予去氨加压素减少出血风险、减少血肿大小，而不增加住院费用。
Prebiopsy desmopressin administration decreases the risk of bleeding and hematoma size in patients undergoing percutaneous kidney biopsy without a cost increase.
应用推荐